logo

For the Inventor, By the Inventor

Tokyo, Japan

Nisshin Pharma Inc.

USPTO Granted Patents = 19

% Expired Patents = 47.4



Forward Citations = 173

Loading Chart...
Loading Chart...

48 inventors (with patents filed for the assignee):

goldMedal Hiroyuki Ikemoto (6 out of 6 patents)

silverMedal Masataka Harata (6 out of 6 patents)

bronzeMedal Tsuyoshi Minemura (4 out of 5 patents)

4.  Koji Kawamura (4 out of 12 patents)

5.  Kenji Takemoto (3 out of 3 patents)

6.  Shingo Nonaka (3 out of 3 patents)

7.  Toshihiro Takahashi (3 out of 53 patents)

8.  Masahiro Ueno (3 out of 8 patents)

9.  Makoto Yanai (3 out of 19 patents)

10.  Masashi Suzuki (3 out of 36 patents)

11.  Hideki Kanai (2 out of 2 patents)

12.  Hironori Kubota (2 out of 4 patents)

13.  Koichi Itoh (2 out of 5 patents)

14.  Hiroyuki Yamazaki (2 out of 6 patents)

15.  Shigeru Hiramoto (2 out of 14 patents)


19 patents:

1. 12275699 - Eicosapentaenoic acid alkyl ester-containing composition and method for producing same (2025-04-14),
2. 11767491 - Eicosapentaenoic acid alkyl ester-containing composition and method for producing same (2023-09-26),
3. 10899994 - Method for producing polyunsaturated fatty acid-containing composition (2021-01-26),
4. 10597607 - Method for producing polyunsaturated fatty acid-containing composition (2020-03-24),
5. 10538793 - ω3 fatty-acid desaturase and method for producing eicosapentaenoic acid (2020-01-21),
6. 9365800 - Method for producing composition containing highly unsaturated fatty acid alkyl ester (2016-06-14),
7. 9340808 - Sulfur amino acid-containing composition (2016-05-17),
8. 8357380 - Coenzyme Q10-containing composition (2013-01-22),
9. 8119113 - [object Object] (2012-02-21),
10. 7470436 - [object Object] (2008-12-30),
11. 7375115 - 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same (2008-05-20),
12. 7026361 - Composition comprising ubiquinone (2006-04-11),
13. 7022732 - Propanolamine derivative having 1, 4-benzodioxane ring (2006-04-04),
14. 6858234 - Process for the preparation of amylase inhibitor (2005-02-22),
15. 6509482 - Optically active 1,4-benzodioxin-2-carboxylic acid derivatives and process for producing the same (2003-01-21),
Company Overview
Nisshin Pharma Inc., based in Tokyo, specializes in the research, development, and manufacturing of pharmaceutical products. The company focuses on innovative therapies across various therapeutic areas, including neurology and oncology. With a commitment to advancing healthcare, Nisshin Pharma leverages cutting-edge technology and scientific expertise to address unmet medical needs. Its strategic initiatives aim to enhance patient outcomes and contribute to the global pharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#1,381 in Tokyo

#3,041 in Japan

#32,693 in the World

Tokyo, JP
Tokyo, Japan

Nisshin Pharma Inc.

Forward Citations = 173

48 inventors:

goldMedal Hiroyuki Ikemoto (6 out of 6 patents)

silverMedal Masataka Harata (6 out of 6 patents)

bronzeMedal Tsuyoshi Minemura (4 out of 5 patents)

4.  Koji Kawamura (4 out of 12 patents)

5.  Kenji Takemoto (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nisshin Pharma Inc.. Retrieved from https://idiyas.com/company/nisshin-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…